Ming Li

Attending in the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, National Medical Center.

[Ming Li @MING_02111]

Such an amazing experience! You never know what the next chapter holds, but this entire story began with an @IASLC Mentorship program in 2024. Great catching up at UC Irvine! 🤝🍔 #ThoracicSurgery #IASLC

[Ming Li @MING_02111]

Working with such a nice Thoracic surgery team in Stanford Hospital. Thx AATS and AATS Foundation @AATSHQ for this incredible opportunity!

[Ming Li @MING_02111]

Surgical resection should remain the preferred option

[Brendon Stiles @BrendonStilesMD]

Can SABR replace surgery for operable stage I NSCLC?

New @JCO_ASCO study by Kagenaar et al. uses England's national cancer data (2015–2020) to compare outcomes in 12,546 patients:

🔹 Surgery: 10,247
🔹 SABR: 2,299
Study: https://t.co/fv55nQlwqI

🧵

[Ming Li @MING_02111]

@hari_keshava @AATSHQ @atscommunity @AmLungCSI @STS_CTsurgery Haha, totally thought he was handing you one to join in😂

[AATS @AATSHQ]

The AATS is pleased to announce Scott A. LeMaire, MD, has been appointed the 11th Editor-in-Chief of the #JTCVS journal family. @scottlemaire @GeisingerRsrch @GeisingerCwlth will begin his new position January 1. View the full press release announcement: https://t.co/34E9JWe42a

[Ming Li @MING_02111]

@hari_keshava Of course, cytology and even NGS. How about the preoperative PET scan and biopsy? the presence of malignant pleural effusion is often associated with pleural met, indicates Stage IV. I would still opt for surgical resection of the primary tumor, followed by adjuvant therapy.

[Ming Li @MING_02111]

@AATSHQ Great job of our study team. Further more studies and IIT trails based on AI are going now!

[AATS @AATSHQ]

Surgeons in China found that femtosecond label-free imaging provides rapid, morphologically concordant pathological assessment with significant workflow advantages over conventional frozen-section analysis. Read in #JTCVS Open: https://t.co/FMmZQ23nxo

[JCOG @JCOG_official]

#JCOG 「肺がん内科グループ治療開発マップ」を更新しました。ぜひご覧ください

🆕治療開発マップ🔎
#肺がん #治療開発マップ #JCOG

https://t.co/irzRtmNN9v

[gilberto lopes @GlopesMd]

Pleasant Surprise from #ASCO26 Abstract 8002 (LORIN): neoadjuvant lorlatinib in stage III ALK+ NSCLC hits a pCR of 46.9% and MPR of 81.3% — pathologic responses we rarely see with neoadjuvant TKIs. 75% of initially unresectable pts converted to surgery. Targeted neoadj earning its seat.

#LCSM
@OncoAlert @OncBrothers @StephenVLiu @Jani_Chinmay @asco @myESMO @glopesmd @SylvesterCancer @latinamd @COlazagasti

[Ming Li @MING_02111]

Honored to be a dual recipient of the AATS Travel Award and Training Fellowship this year! 🏆
A huge thank you to @AATSHQ and the AATS Foundation! These opportunities provide a window to a wider world and innovation in our field!🫁✨#AATS2026 #ThoracicSurgery #AATSFoundation

[Ming Li @MING_02111]

we welcome technical notes and videos of uniportal VATS procedures for anatomical lung surgery
https://t.co/amoredX6B4

[Hari B. Keshava @hari_keshava]

It was a phenomenal time hosting Drs Ming Li and Qing Liang with the @IASLC International Mentorship Program! We exchanged OR techniques and talked about management of GGOs and mutations in lung cancer! Together we can stop lung cancer! #wclc2024 #lungcancer @MING_02111

[Ming Li @MING_02111]

-How can we say goodbye?
-As we say hello in San Diego!
Sincerely thanks to Prof.Keshava, and thank the IASLC. Thank you so much for giving me such a wonderful opportunity, a chance to see the world!
@hari_keshava @IASLC

[Ming Li @MING_02111]

#WCLC24 @IASLC 有幸获得WCLC2024 International Mentorship Award，感谢IASLC的资助，感谢小臧的见证，计划的秋天终将褪去童话的色彩 。

[Ming Li @MING_02111]

#WCLC24 @IASLC
😝

[Ming Li @MING_02111]

@NarjustFlorezMD @IASLC Nice bag, i want to buy one😀

[Ming Li @MING_02111]

Can't wait #WCLC24

[Ming Li @MING_02111]

#WCLC24 @IASLC I am deeply honored to be a recipient of the 2024 International Mentorship Award. I will have two presentations (mini oral and poster), great honor for me!